EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report

Shohei Otsuka, Kei Hiraoka, Nozomu Iwashiro

Cureus · 01.06.2026

DOI: 10.7759/cureus.110026 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 01.06.2026. Verfasst von Shohei Otsuka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Hospital Organization (NHO) Hakodate Medical Center, Hakodate, JPN. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

immune-related adverse eventsmalignant pleural mesotheliomanivolumabprogression-free survivalsecond-line therapy

Autor:innen und Institutionen

  • Department of Surgery, National Hospital Organization (NHO) Hakodate Medical Center, Hakodate, JPN.

Zitieren

APA

Otsuka, S., Hiraoka, K., & Iwashiro, N. (2026). Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report. Cureus. https://doi.org/10.7759/cureus.110026

Vancouver

Otsuka S, Hiraoka K, Iwashiro N. Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report. Cureus. 2026. doi:10.7759/cureus.110026

BibTeX
@article{Otsuka2026,
  author = {Otsuka, Shohei and Hiraoka, Kei and Iwashiro, Nozomu},
  title = {Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.110026}
}
Kostenlos starten →